INNORNA’s Covid mRNA Vaccine Approved by New Zealand for Phase I Clinical Trial

Shenzhen, December 20, 2022—INNORNA announced that New Zealand Medicines and Medical Devices Safety Administration (MEDSAFE) approved a phase I clinical trial for its COVID-19 vaccine to conduct Head to Head comparative study against mRNA vaccines on the market in Europe and the United States.